Dual Modes of Death Induced by Etoposide in Human Epithelial Tumor Cells Allow Bcl-2 to Inhibit Apoptosis without Affecting Clonogenic Survival

作者: Lolita Stribinskiene , Richard B. Lock

DOI:

关键词: Cancer researchViability assayMitotic catastropheCell growthProgrammed cell deathEtoposideApoptosisImmunologyTrypan blueTransfectionBiology

摘要: Abstract The Bcl-2 oncoprotein, which is expressed in a variety of human malignancies, blocks apoptosis induced by chemotherapeutic drugs, including the topoisomerase II inhibitor, etoposide. To determine significance etoposide-induced death epithelial tumor cells, HeLa S3 cells were transfected with bcl-2 cDNA pSFFV expression vector, and stable Bcl-2-expressing clones established. In agreement previous studies, inhibited loss cell viability (by trypan blue exclusion), appearance morphologically apoptotic amount low molecular weight DNA extracted after etoposide exposure (25 µm, 4 h). degree inhibition, compared to wild-type vector control-transfected clones, differed according level protein two studied. However, when survival was assessed colony-forming assays, no significant differences detected at any concentrations used. Although apoptosis, it had effect on formation giant, multinucleated characteristic mitotic catastrophe. Consequently, ability prevent caused drugs may not necessarily translate into increased that express Bcl-2.

参考文章(33)
Yves Pommier, Jeffrey Cossman, Timothy J. Jorgensen, Hiroshi Kamesaki, Akihiko Tanizawa, Saori Kamesaki, bcl-2 Protein Inhibits Etoposide-induced Apoptosis through Its Effects on Events Subsequent to Topoisomerase II-induced DNA Strand Breaks and Their Repair Cancer Research. ,vol. 53, pp. 4251- 4256 ,(1993)
Satadal Chatterjee, Hisako Hashimoto, Nathan A. Berger, Inhibition of Etoposide (VP-16)-induced DNA Recombination and Mutant Frequency by Bcl-2 Protein Overexpression Cancer Research. ,vol. 55, pp. 4029- 4035 ,(1995)
Mark A. Israel, Antonio Iavarone, Anna Lasorella, Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. Cancer Research. ,vol. 55, pp. 4711- 4716 ,(1995)
Richard C. Feldhoff, Richard B. Lock, Lori J. Rhodes, Olga V. Galperina, Concentration-dependent Differences in the Mechanisms by Which Caffeine Potentiates Etoposide Cytotoxicity in HeLa Cells Cancer Research. ,vol. 54, pp. 4933- 4939 ,(1994)
P Verderio, O Caffo, C Doglioni, P Bevilacqua, M Barbareschi, L Morelli, P Boracchi, G Gasparini, P D Palma, F A Mauri, Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clinical Cancer Research. ,vol. 1, pp. 189- 198 ,(1995)